Back to search

University of Southampton

Microglial motility and morphology in Alzheimer's Disease, and after Aβ42- immunotherapy

Abstract

dc:description.abstract

Microglia are the resident immune cells of the brain. Their main functions in the adult <br/>brain are to provide protection against pathogens and to remove cellular debris via <br/>phagocytosis. Microglial function is highly dependent on cell motility. Evidence from <br/>Alzheimer’s disease (AD) animal models supports microglial motility impairment in AD, possibly linked to Aβ accumulation. In AD patients immunised against Aβ42, Aβ plaque removal is partly due to phagocytic microglia, supporting an association between microglial function and Aβ clearance. <br/> The aim of the present study is to evaluate the expression of microglial motility-related proteins, as well as microglial morphological features, in the inferior parietal lobule of 32 controls, 44 AD cases and 16 immunised AD (iAD) cases, patients who had been immunised against the Aβ42 peptide. Immunohistochemistry (IHC) was performed for the proteins Iba1, CFL1, CORO1A and P2RY12, and protein load was assessed with an automated image analysis method. The neuroinflammatory environment was evaluated with Meso Scale Discovery protein immunoassays. Iba1 IHC was also used for microglial cell counting and morphological analysis. Fluorescent Iba1 IHC, confocal microscopy and semi-automated 3Dreconstruction were used for detailed assessment of microglial morphological features.<br/> Among the most relevant results, the levels of the motility-related proteins studied showed no difference in AD cases compared to controls. In the iAD group compared to AD, the levels of Iba1 were increased in grey and white matter, and the level of P2RY12 in the grey matter only.There was no difference in the total number of microglia in AD compared to controls, but there was an increase in iAD compared to AD. The ramified population was reduced in AD compared to controls, while in iAD both the ramified and amoeboid populations were increased. The microglial cell body volume was increased in AD compared to controls, whereas the total process length was increased in iAD <br/>compared to AD. <br/> Our results highlight some potentially relevant effects of the disease, and of Aβimmunotherapy on microglial motility, and help further our understanding of the functional spectrum of microglia in health and disease.

Degree

thesis:*
Name dc:type.qualificationname
Ph.D.
Level dc:type.qualificationlevel
doctoral
Year dc:date.issued
2020

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Franco Bocanegra, Diana Karina
Advisors dc:contributor.advisor
  • Boche, Delphine
  • Nicoll, James
ORCID person:identifier.orcid

Rights

Language dc:language
English, eng

Chain of custody

source
Harvested from
University of Southampton
Base URL
eprints.soton.ac.uk/cgi/oai2
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Franco Bocanegra, Diana Karina. Microglial motility and morphology in Alzheimer's Disease, and after Aβ42- immunotherapy. doctoral thesis, 2020.